Cannabis

Revenue in the Cannabis market in ASEAN is forecasted to reach US$410.80m in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 2.96%, leading to a market volume of US$475.20m by 2029.
When compared globally, the United States is expected to generate the highest revenue (US$42.98bn in 2024).
In terms of per person revenues in 2024, US$118.10 is generated in relation to the total population figures.
In ASEAN, the Cannabis market is gaining traction as regulatory environments evolve, presenting investment opportunities in Cannabis-related commodities.

Definition:
The Cannabis market covers products derived from the cannabis plant used for medical or recreational purposes. These products may include dried flowers, oils, edibles, tinctures, and topicals. Depending on the regulations in each country or state, these products are provided by dispensaries, pharmacies, and/or online platforms. They may be consumed in the form of smoking, vaporizing, eating, or applying topically.

Structure:
The market includes Medical, Pharmaceutical, and Recreational Cannabis as well as CBD Products. The Medical and Pharmaceutical Cannabis markets include products used to treat conditions such as chronic pain, mental disorders, and other medical conditions. The Recreational Cannabis and the the CBD Products markets include products used for personal enjoyment or leisure purposes. All cannabis markets include various forms of cannabis such as flowers, concentrates, edibles, and topicals.

Additional information:
Market values represent the revenues generated by retail prices paid to vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Canopy Growth Corporation, Aurora Cannabis, Curaleaf Holdings, Tilray, Green Thumb Industries, Trulieve Cannabis, Verano Holdings.

Recreational Cannabis
Medical Cannabis
Pharmaceutical Cannabis
CBD Products

Illegal cannabis
Cannabis cultivated for private use

The ASEAN region has seen a growing interest in the Cannabis market in recent years, with several countries exploring opportunities within the industry.

Customer preferences: Customers in ASEAN countries are increasingly looking for alternative medical treatments and wellness products, driving the demand for Cannabis-based products. The shift towards natural and holistic remedies has influenced consumer preferences towards Cannabis for its potential health benefits.

Trends in the market: In Thailand, the legalization of medical Cannabis in 2018 has paved the way for a budding industry. The country has been focusing on research and development of Cannabis-based pharmaceuticals, attracting both local and foreign investors. Similarly, Malaysia has been exploring the potential of Cannabis for medical purposes, with discussions ongoing about potential legalization.

Local special circumstances: Indonesia, on the other hand, has stricter regulations against Cannabis, largely due to cultural and religious factors. The country's conservative stance on Cannabis has limited market growth compared to its neighbors. In contrast, the Philippines has shown interest in Cannabis for medical use, but regulatory frameworks are still being developed.

Underlying macroeconomic factors: The varying pace of Cannabis market development in ASEAN countries can be attributed to different regulatory environments, cultural attitudes, and government policies. Economic factors such as foreign investment, job creation, and tax revenues are also influencing the growth of the Cannabis market in the region. Additionally, the potential for Cannabis to become a major export commodity is driving some countries to further explore its economic benefits.

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Cannabis or marijuana, the psychoactive drug from the cannabis plant is growing in popularity around the globe, both for recreational and medicinal uses. While there are many countries that have legalized cannabis in some capacity for medical purposes, only a handful have done so for recreational use. Even though cannabis is not federally legal in the United States, the combined legal states represent the largest market in the world. After the U.S., Canada, which legalized cannabis nation-wide in 2018 represents the next largest market. In 2021, a new coalition government was formed in Germany that indicated that the legalization of cannabis was on their agenda. Germany would be the largest legal adult-use market in Europe and would act as a test case for other countries on the continent considering the merits of legalization.